Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Royalty Pharma plc
< Previous
1
2
Next >
Royalty Pharma Declares Fourth Quarter 2023 Dividend
October 16, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
October 11, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Appoints Eric Schneider as Chief Technology Officer
September 21, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
September 05, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
ASND
RPRX
Royalty Pharma to Present at Upcoming Investor Conferences
September 05, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma and Ferring Pharmaceuticals Enter Into US $500 Million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (Nadofaragene Firadenovec-Vncg)
August 24, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Reports Second Quarter 2023 Results
August 08, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce Second Quarter 2023 Financial Results on August 8, 2023
July 18, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Declares Third Quarter 2023 Dividend
July 17, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
June 07, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Reports First Quarter 2023 Results
May 09, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma To Present At The BofA Securities 2023 Health Care Conference
May 03, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Declares Second Quarter 2023 Dividend
April 17, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce First Quarter 2023 Financial Results on May 9, 2023
April 13, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces $1.0 Billion Share Repurchase Program
March 27, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 Million
March 23, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
PRTC
RPRX
Royalty Pharma Raises Full Year 2023 Guidance
March 15, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Appoints Ashwin Pai as Executive Vice President, Investments
March 01, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Reports Q4 and Full Year 2022 Results
February 15, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at Upcoming Investor Conferences
February 09, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma To Announce Fourth Quarter And Full Year 2022 Financial Results On February 15, 2023
January 18, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Highlights Accomplishments and Provides Business Update at 41st Annual J.P. Morgan Healthcare Conference
January 09, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial Readiness
January 09, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
IONS
RPRX
Royalty Pharma Announces Dividend Increase
January 09, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 9
January 04, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Expansion of Senior Leadership Team
December 15, 2022
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference
November 28, 2022
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran From Arrowhead for $250 million and Future Milestones
November 09, 2022
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
ARWR
RPRX
Royalty Pharma Reports Third Quarter 2022 Results
November 08, 2022
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce Third Quarter 2022 Financial Results on November 8, 2022
October 18, 2022
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
